PATRICK JASON O'CONNOR
Pilots at Lebanon Rd, New Haven, CT

License number
Connecticut A4471960
Issued Date
Jul 2015
Expiration Date
Jul 2016
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
139 Lebanon Rd, New Haven, CT 06524

Professional information

Patrick O'Connor Photo 1

Patrick O'Connor, New Haven CT

Work:
Yale-New Haven Hospital
789 Howard Ave, New Haven, CT 06519 Yale Physicians Practice
800 Howard Ave, New Haven, CT 06519


Patrick O'Connor Photo 2

Smoking Cessation Treatments Using Naltrexone And Related Compounds

US Patent:
6004970, Dec 21, 1999
Filed:
Nov 12, 1997
Appl. No.:
8/952402
Inventors:
Stephanie O'Malley - New Haven CT
Boris Meandzija - Hamden CT
Suchitra Krishnan-Sarin - Durham CT
Patrick G. O'Connor - Woodbridge CT
Assignee:
Yale University - New Haven CT
International Classification:
A01N 4342
US Classification:
514282
Abstract:
Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrexone or a mixture of any one of these, and either clonidine or related compounds either while awake, or while under sedation or anesthesia, followed by continued administration of an effective amount of an opioid antagonist with or without agents that enhance nicotine dependency treatment. Persons are also treated for nicotine dependency with more gradual detoxification methods using administration of a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone, naltrexone, or a mixture of any of these, and an effective amount of agents used to treat nicotine withdrawal including nicotine, such as that delivered by a nicotine patch, nicotine chewing gum, nicotine inhaler or other methods for delivering nicotine, antidepressants and antianxiety agents, and/or clonidine and related compounds. Administration of an effective amount of an opioid antagonist to prevent relapse, attenuate craving, and reduce weight gain during and after treatment for nicotine dependency is continued in some embodiments.